Norwegian start-up aims to unlock the potential of marine bioactives for cancer treatment

KinSea announces first closing of seed financing

01-May-2024 - KinSea Lead Discovery AS, a biopharmaceutical start-up pioneering the use of marine bioactives for the treatment of human diseases, announces the successful first closing of its seed financing round. It includes an equity investment from KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I), an ...

Leukaemia: artificial intelligence provides support in diagnostics

IT specialists and physicians develop new method for recognising genetic aberrations

16-Jan-2024 - Decisions on treatment for patients with acute myeloid leukemia(AML) – a highly aggressive form of leukemia– are based, among other things, on a series of certain genetic features of the disease; but at the time when a diagnosis is made, this information is not available. However, evidence of ...

Leukemia cells activate cellular recycling program

The findings open up new therapeutic options for the future

08-Dec-2023 - To speed up their growth, leukemia cells typically activate the recycling of cellular structures – enabling them to dispose of defective components and better supply themselves with building materials. Researchers at Goethe University Frankfurt have now shown that leukemia cells with a very ...

Pediatric oncology: Scientists discover new Achilles heel of leukemia cells

New, unforeseen possibility in the fight against blood cancer

22-Nov-2023 - Leukemia is the most common type of cancer in children. Treatment involves intensive chemotherapy, which has severe side effects due to its non-specific mode of action. A team from the Department of Pediatrics and the Institute for Experimental Pediatric Hematology and Oncology at Goethe ...

RIANA Therapeutics enters into collaboration agreement with LDC

"This cooperation has the great potential to lay the groundwork for new, urgently needed therapeutic approaches for AML patients"

13-Sep-2023 - RIANA Therapeutics, a spin-off from Vetmeduni Vienna has entered into a collaborative agreement with the Lead Discovery Center GmbH, a renowned organization specialized in translational drug discovery. This partnership marks the first important milestone on RIANA Therapeutics´ mission to discover ...

RIANA Therapeutics signs license agreement with Vetmeduni and expands team

21-Jun-2023 - In spring 2023, RIANA Therapeutics, a spin-off of Vetmeduni, kicked off its operations. With the aim of developing innovative cancer therapeutics, this biotech start-up leverages groundbreaking scientific insights from Vetmeduni's Unit of Functional Cancer Genomics. A significant milestone has ...

New insights into the genetic basis of leukemia

Research team discovers links between certain gene mutation and the spatial structure of DNA in blood cancer at an advanced age

26-Jan-2023 - Acute myeloid leukemia (AML) is a malignant disease of the haematopoietic system that originates from immature precursors of red blood cells, platelets and part of the white blood cells. While in healthy people the multiplication and renewal of blood cells is strictly regulated this process gets ...

Improving the effectiveness of existing chemotherapy

Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m

15-Sep-2022 - Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer micro-environment announces the final close of its Series A financing, with total funds raised of €17.3 million. The funds will be used to complete development and ...

Study reveals decisive role of PDK1 enzyme in acute myeloid leukaemia

PDK1: a determining factor in different metabolic states

01-Apr-2022 - Acute myeloid leukaemia (AML) remains harder to treat therapeutically due to the high existing genetic heterogeneity not only between patients but also between the population of subclones of cancer cells within the same person. Despite the knowledge advances, understanding the metabolic ...

Avocado discovery may point to leukemia treatment

04-May-2021 - A compound in avocados may ultimately offer a route to better leukemia treatment, says a new University of Guelph study. The compound targets an enzyme that scientists have identified for the first time as being critical to cancer cell growth, said Dr. Paul Spagnuolo, Department of Food ...